TherapeuticsMD annual meeting votes: all director nominees elected, say-on-pay approved, auditor ratified

TherapeuticsMD, Inc.

All four board nominees elected: Thompson 4.60M for, Collins 4.73M, Naughton 4.64M, Roberts 4.63M; broker non-votes 1.97M each.
Non-binding advisory vote on 2023 exec comp: 4.61M for, 218K against, 30K abstain; broker non-votes 1.97M.
Ratification of Berkowitz Pollack Brant as auditor for FY2024: 6.44M for, 383K against, 12K abstain; no broker non-votes.
Meeting held Dec 5, 2024; quorum of 6.83M shares (59.2% of 11.53M outstanding shares).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.